Pioglitazone boosts conventional lipid-lowering therapy for familial combined hyperlipidemia

Author：  

Publisher： Future Medicine

ISSN： 1746-0875

Source： Future Lipidology, Vol.2, Iss.3, 2007-06, pp. : 259-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond lipid-lowering therapy: does ezetimibe enhance the effects of statins on atherosclerosis?

By Krishnamoorthy Suresh   Lip Gregory YH  

Therapy, Vol. 5, Iss. 4, 2008-07 ,pp. : 487-489

Future Medicine

Access to resources Recommend Favorite

Meta-Analysis of Lipid-Lowering Therapy in Maintenance Dialysis Patients

By  

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2014-01 ,pp. : 209-217

Karger

Access to resources Recommend Favorite

Seasonal Variation of Lipid-Lowering Effects of Complex Spa Therapy

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 10, Iss. 2, 2003-05 ,pp. : 78-84

Karger

Access to resources Recommend Favorite

Lipid‐lowering therapy use and achievement of cholesterol targets in an Australian diabetes clinic

By  

INTERNAL MEDICINE JOURNAL, Vol. 48, Iss. 2, 2018-02 ,pp. : 201-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Unraveling the complex genetics of familial combined hyperlipidemia

By Suviolahti Elina   Lilja Heidi   Pajukanta Päivi  

Annals of Medicine, Vol. 38, Iss. 5, 2006-09 ,pp. : 337-351

Informa Healthcare

Access to resources Recommend Favorite